Semler Scientific (NASDAQ:SMLR) Trading Up 7.1% – Still a Buy?

Semler Scientific, Inc. (NASDAQ:SMLR)’s share price was up 7.1% during mid-day trading on Monday . The stock traded as high as $61.50 and last traded at $61.08. Approximately 445,802 shares were traded during mid-day trading, an increase of 71% from the average daily volume of 261,239 shares. The stock had previously closed at $57.02.

Semler Scientific Price Performance

The business’s 50 day simple moving average is $35.84 and its 200 day simple moving average is $32.09. The stock has a market cap of $503.23 million, a P/E ratio of 27.81 and a beta of 0.92.

Semler Scientific (NASDAQ:SMLR) last issued its quarterly earnings data on Monday, November 4th. The company reported $0.72 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.37 by $0.35. The company had revenue of $13.51 million during the quarter. Semler Scientific had a return on equity of 20.31% and a net margin of 27.00%.

Hedge Funds Weigh In On Semler Scientific

A number of institutional investors and hedge funds have recently bought and sold shares of the business. Sanctuary Advisors LLC acquired a new stake in shares of Semler Scientific in the third quarter valued at $104,000. Geode Capital Management LLC grew its holdings in Semler Scientific by 10.5% during the 3rd quarter. Geode Capital Management LLC now owns 135,959 shares of the company’s stock worth $3,202,000 after acquiring an additional 12,964 shares during the last quarter. Jane Street Group LLC increased its position in Semler Scientific by 72.3% in the 3rd quarter. Jane Street Group LLC now owns 16,982 shares of the company’s stock valued at $400,000 after acquiring an additional 7,126 shares in the last quarter. State Street Corp raised its stake in shares of Semler Scientific by 0.6% in the third quarter. State Street Corp now owns 118,223 shares of the company’s stock worth $2,784,000 after acquiring an additional 725 shares during the last quarter. Finally, Verition Fund Management LLC acquired a new position in shares of Semler Scientific during the third quarter worth approximately $251,000. Institutional investors and hedge funds own 49.37% of the company’s stock.

About Semler Scientific

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition.